AGI-6780, a potent and selective allosteric inhibitor of the IDH2-R140Q mutations was recently reported to significantly induce differentiation in primary AML cells bearing IDH2-R140Q in ex vivo cultures. The gene discussed is IDH2; the disease is acute myeloid leukemia.